<VariationArchive RecordType="classified" VariationID="1119995" VariationName="NM_000500.9(CYP21A2):c.833dup (p.Glu279fs)" VariationType="Duplication" Accession="VCV001119995" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2021-06-03" MostRecentSubmission="2021-06-03">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1108772" VariationID="1119995">
      <GeneList>
        <Gene Symbol="CYP21A2" FullName="cytochrome P450 family 21 subfamily A member 2" GeneID="1589" HGNC_ID="HGNC:2600" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>6p21.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NT_167248.2" start="3261650" stop="3264877" display_start="3261650" display_stop="3264877" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="32038415" stop="32041644" display_start="32038415" display_stop="32041644" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NT_113891.3" start="3476737" stop="3479966" display_start="3476737" display_stop="3479966" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NT_167245.2" start="3279823" stop="3283052" display_start="3279823" display_stop="3283052" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NT_167247.2" start="3380452" stop="3383677" display_start="3380452" display_stop="3383677" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NT_167249.2" start="3339605" stop="3342831" display_start="3339605" display_stop="3342831" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="32006092" stop="32009446" display_start="32006092" display_stop="32009446" Strand="+" />
          </Location>
          <OMIM>613815</OMIM>
        </Gene>
        <Gene Symbol="LOC106780800" FullName="CYP21A2 recombination region" GeneID="106780800" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>6p21.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="32037872" stop="32041144" display_start="32037872" display_stop="32041144" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NT_167247.2" start="3379909" stop="3383177" display_start="3379909" display_stop="3383177" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_000500.9(CYP21A2):c.833dup (p.Glu279fs)</Name>
      <CanonicalSPDI>NC_000006.12:32040098:T:TT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>6p21.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="32040098" stop="32040099" display_start="32040098" display_stop="32040099" variantLength="1" positionVCF="32040098" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="32007875" stop="32007876" display_start="32007875" display_stop="32007876" variantLength="1" positionVCF="32007875" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
      </Location>
      <ProteinChange>E144fs</ProteinChange>
      <ProteinChange>E249fs</ProteinChange>
      <ProteinChange>E279fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_829" sequenceAccession="LRG_829">
            <Expression>LRG_829:g.6795dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000500.9" sequenceAccession="NM_000500" sequenceVersion="9" change="c.833dupT" MANESelect="true">
            <Expression>NM_000500.9:c.833dupT</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.32007876dup" Assembly="GRCh37">
            <Expression>NC_000006.11:g.32007876dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.32040099dup" Assembly="GRCh38">
            <Expression>NC_000006.12:g.32040099dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007941.3" sequenceAccession="NG_007941" sequenceVersion="3" change="g.6795dup">
            <Expression>NG_007941.3:g.6795dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008337.2" sequenceAccession="NG_008337" sequenceVersion="2" change="g.74276dup">
            <Expression>NG_008337.2:g.74276dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_045215.1" sequenceAccession="NG_045215" sequenceVersion="1" change="g.2328dup">
            <Expression>NG_045215.1:g.2328dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000500.9" sequenceAccession="NM_000500" sequenceVersion="9" change="c.833dup" MANESelect="true">
            <Expression>NM_000500.9:c.833dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000491.4" sequenceAccession="NP_000491" sequenceVersion="4" change="p.Glu279fs">
            <Expression>NP_000491.4:p.Glu279fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001128590.4" sequenceAccession="NM_001128590" sequenceVersion="4" change="c.743dup">
            <Expression>NM_001128590.4:c.743dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001122062.3" sequenceAccession="NP_001122062" sequenceVersion="3" change="p.Glu249fs">
            <Expression>NP_001122062.3:p.Glu249fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001368143.2" sequenceAccession="NM_001368143" sequenceVersion="2" change="c.428dup">
            <Expression>NM_001368143.2:c.428dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001355072.1" sequenceAccession="NP_001355072" sequenceVersion="1" change="p.Glu144fs">
            <Expression>NP_001355072.1:p.Glu144fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001368144.2" sequenceAccession="NM_001368144" sequenceVersion="2" change="c.428dup">
            <Expression>NM_001368144.2:c.428dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001355073.1" sequenceAccession="NP_001355073" sequenceVersion="1" change="p.Glu144fs">
            <Expression>NP_001355073.1:p.Glu144fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_829t1" sequenceAccession="LRG_829t1">
            <Expression>LRG_829t1:c.833dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_829p1" sequenceAccession="LRG_829p1" change="p.Glu279fs">
            <Expression>LRG_829p1:p.Glu279fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2151874375" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000500.9(CYP21A2):c.833dup (p.Glu279fs) AND Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency" Accession="RCV001449920" Version="1">
        <ClassifiedConditionList TraitSetID="3295">
          <ClassifiedCondition DB="MedGen" ID="C2936858">Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2021-05-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-05-18" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-06-03" MostRecentSubmission="2021-06-03">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="3295" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="10963" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Congenital adrenal hyperplasia due to 21-hydroxylase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">CYP21 deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia</ElementValue>
                <XRef ID="NBK1171" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency</ElementValue>
                <XRef ID="MONDO:0008728" DB="MONDO" />
                <XRef ID="90794" DB="Orphanet" />
                <XRef ID="717261006" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">21-hydroxylase deficiency (21-OHD) is the most common cause of congenital adrenal hyperplasia (CAH), a family of autosomal recessive disorders involving impaired synthesis of cortisol from cholesterol by the adrenal cortex. In 21-OHD CAH, excessive adrenal androgen biosynthesis results in virilization in all individuals and salt wasting in some individuals. A classic form with severe enzyme deficiency and prenatal onset of virilization is distinguished from a non-classic form with mild enzyme deficiency and postnatal onset. The classic form is further divided into the simple virilizing form (~25% of affected individuals) and the salt-wasting form, in which aldosterone production is inadequate (=75% of individuals). Newborns with salt-wasting 21-OHD CAH are at risk for life-threatening salt-wasting crises. Individuals with the non-classic form of 21-OHD CAH present postnatally with signs of hyperandrogenism; females with the non-classic form are not virilized at birth.</Attribute>
                <XRef ID="NBK1171" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12665" />
                <XRef ID="12665" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301350</ID>
                <ID Source="BookShelf">NBK1171</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT Sheet, 2011">
                <URL>https://www.ncbi.nlm.nih.gov/books/NBK55827/bin/CAH.pdf</URL>
                <CitationText>American College of Medical Genetics ACT SHEET, Congenital Adrenal Hyperplasia, 2011</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2009">
                <URL>https://www.ncbi.nlm.nih.gov/books/NBK55827/bin/Visio-NBS_Elevated_17OHP.pdf</URL>
                <CitationText>American College of Medical Genetics Algorithm, Congenital Adrenal Hyperplasia, 2009</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="ESCGS, 2010">
                <ID Source="pmc">2936060</ID>
              </Citation>
              <Citation Type="general" Abbrev="ES, 2018">
                <ID Source="PubMed">30272171</ID>
                <ID Source="pmc">6456929</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2009">
                <URL>https://www.acmg.net/PDFLibrary/Elevated-17-OHP-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Congenital Adrenal Hyperplasia (Elevated 17-OHP), 2009</CitationText>
              </Citation>
              <XRef ID="90794" DB="Orphanet" />
              <XRef ID="C2936858" DB="MedGen" />
              <XRef ID="MONDO:0008728" DB="MONDO" />
              <XRef Type="MIM" ID="201910" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3255196" SubmissionDate="2021-05-24" DateLastUpdated="2021-06-03" DateCreated="2021-06-03">
        <ClinVarSubmissionID localKey="SUB9683855" submittedAssembly="GRCh37" title="SUB9683855" />
        <ClinVarAccession Accession="SCV001623017" DateUpdated="2021-06-03" DateCreated="2021-06-03" Type="SCV" Version="1" SubmitterName="Department of Pediatric Endocrinology and Inherited Metabolic Diseases, Children's Hospital of Fudan University" OrgID="508091" OrganizationCategory="clinic" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-05-18">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.833dupT variant in CYP21A2 was discovered in 1 chinese CAH patient with p.I173N on the other allel presenting as SV CAH.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Ethnicity>Asian</Ethnicity>
              <GeographicOrigin>China</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="CompoundHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet DateLastEvaluated="2021-05-19" Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0008221" />
              </Trait>
              <Comment>SV form CAH</Comment>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYP21A2">
              <Name>cytochrome P450 family 21 subfamily A member 2</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000500.9:c.833dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="201910" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB9683855</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3255196" TraitType="Disease" MappingType="XRef" MappingValue="201910" MappingRef="OMIM">
        <MedGen CUI="C2936858" Name="Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3255196" TraitType="Finding" MappingType="XRef" MappingValue="HP:0008221" MappingRef="HP">
        <MedGen CUI="C1621895" Name="Adrenal hyperplasia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

